Table 1.
Demographic and pathological data of 215 differentiated thyroid cancer patients.
| Total | Group A | Group B | P | |
|---|---|---|---|---|
| Patients | 215 | 169 | 46 | |
| Male | 42 (19.53%) | 34 (20.11%) | 8 (17.39%) | 0.8384 |
| Female | 173 (80.46%) | 135 (79.88%) | 38 (82.60%) | |
| Mean age (years) | 51.2 ± 14.34 | 52.3 ± 14 | 47.15 ± 15.01 | 0.0303 |
| Histology | ||||
| Papillary classic | 135 (62.79%) | 102 (60.35%) | 33 (71.73%) | 0.36 |
| Follicular variant | 53 (24.65%) | 42 (24.85%) | 11 (23.91%) | |
| Hürthle cell variant | 5 (2.32%) | 5 (2.95%) | 0 | |
| Tall cell variant | 4 (1.86%) | 4 (2.36%) | 0 | |
| Follicular | 18 (8.37%) | 16 (9.46%) | 2 (4.34%) | |
| Tumor | ||||
| Mean size (mm) | 15.33 | 15.1 | 16.17 | 0.5215 |
| Unique | 153 (71.16%) | 125 (73.96%) | 28 (60.86%) | 0.12 |
| Multifocal | 62 (28.83%) | 44 (26.03%) | 18 (39.13%) | |
| Microcarcinoma | 48 (22.32%) | 41 (24.26%) | 7 (15.21%) | 0.2686 |
| Locoregional infiltration | 52 (24.18%) | 32 (18.93%) | 20 (43.47%) | 0.0011 |